The effect of Metoclopramide and Ondansetron on Etomidate injection pain

Comparison of the efficacy of Metoclopramide and Ondansetron on altering the pain of Etomidate injection under general anesthesia

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20160307026950N32

Enrollment

Registered

2021-03-07

Start date

2021-04-04

Completion date

Unknown

Last updated

2021-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain due to Etomidate injection.

Interventions

Intervention 1: Intervention group A: Patients in this group after receiving the surgical bed and monitoring connection receive 10 mg of Metoclopramide and 10 minutes later 5 ml of distilled water, th

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Aged 18 to 65 years criteria Anesthesia grade 1 and 2 according to ASA (American society Anesthesia) Candidates for elective surgery and Require general anesthesia with atomiditis

Exclusion criteria

Exclusion criteria: Allergy to the Etomidate Allergy to the Metocloramide Allergy to the Ondansetrone

Design outcomes

Primary

Measure	Time frame
Pain due to atomeditis injection. Timepoint: Immediately after the intervention. Method of measurement: By scoring with VAS (visual analog scale) from 1 (painless) to 2 (worst pain imaginable).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZiba Zekavat

Esfahan University of Medical Sciences

behzad_nazem@med.mui.ac.ir+98 31 3620 2020

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026